Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Clinical trial NCT04624230 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04624230
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-12
- Primary completion
- 2027-03-17
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.